<?xml version="1.0" encoding="UTF-8"?>
<item tstamp="2020-06-09-16:19:36">
   <meta name="journal">BMJ</meta>
   <meta name="pub-id">abrd041828</meta>
   <meta name="file">bmj.k872</meta>
   <meta name="section">Research</meta>
   <meta name="series"/>
   <meta name="title">Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study</meta>
   <meta name="first-auth">Devin Abrahami</meta>
   <meta name="graphics">abrd041828.f1,abrd041828.f2</meta>
   <meta name="data-supps">abrd041828.ww1</meta>
   <meta name="username">la_bmjprod</meta>
   <meta name="status"
         report="../qa_reports/abrd041828-QA-report.html"
         sent="true">Sent to HWX</meta>
   <meta name="info"/>
   <meta name="pub.hwx">ppr</meta>
   <meta name="embargo.date">2018/3/21</meta>
   <meta name="embargo.time"/>
   <meta name="vol">360</meta>
   <meta link="http://dx.doi.org/10.1136/bmj.k872" name="hwbatch">bmj_arts_360_mar21_6</meta>
</item>
